David A. Kircher

733 citations
11 papers · 268 indexed · h-index 8
Topics
Melanoma and MAPK Pathways (8 papers)Cellular Mechanics and Interactions (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)
Partner nations
United States

In The Last Decade

David A. Kircher

11 papers receiving 267 citations

Peers

David A. Kircher
Comparison fields: 5 of 51
  • Molecular Biology 197
  • Oncology 108
  • Pulmonary and Respiratory Medicine 70
  • Immunology 39
  • Cancer Research 32
Replace Neil T. Conlon with:
Neil T. Conlon Ireland
Chuanchuan Li United States
Liv Johannessen United States
Alberto Vides United States
Anna M. Schmoker United States
T. Trang United States
Ruth E. Feltell United Kingdom
Mohammed U. Syed United States
Kalle Ojala Finland
Hélène Malka-Mahieu France
David A. Kircher relative to Neil T. Conlon Ireland Neil T. Conlon's profile →
Citations per field
00.5×4.8×
Neil T. Conlon · 1×
Citations per year

Countries citing papers authored by David A. Kircher

Since Specialization
Citations

This map shows the geographic impact of David A. Kircher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Kircher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Kircher more than expected).

Fields of papers citing papers by David A. Kircher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Kircher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Kircher. The network helps show where David A. Kircher may publish in the future.

Co-authorship network of co-authors of David A. Kircher

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Kircher. A scholar is included among the top collaborators of David A. Kircher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Kircher. David A. Kircher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 2
2 4
3 1
4 10
5 21
6 44
7 17
8 8
9 9
10 47
11 105

About David A. Kircher

David A. Kircher is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology, having authored 11 papers that have together received 268 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (8 papers), Cellular Mechanics and Interactions (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (108 citations), Molecular Biology (197 citations) and Genetics (23 citations). David A. Kircher has collaborated with scholars based in United States. Frequent co-authors include Sheri L. Holmen, Matthew W. VanBrocklin, Allie H. Grossmann, Mark R. Silvis, Martin McMahon, Michael A. Davies, James P. Robinson, Pauline Cho, Guo Chen and William J. Burnett. Their work appears in journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026